These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10688736)

  • 21. What do we really know about Helicobacter pylori in gastric ulcer disease?
    Labenz J
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):204-7. PubMed ID: 9646209
    [No Abstract]   [Full Text] [Related]  

  • 22. Peptic ulcers and bacterial infections.
    Harv Mens Health Watch; 2007 Jun; 11(11):1-4. PubMed ID: 17644840
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cost-effectiveness of the eradication of Helicobacter pylori in the treatment of duodenal ulcer].
    Domínguez Muñoz JE
    An Med Interna; 1998 Oct; 15(10):513-4. PubMed ID: 9844224
    [No Abstract]   [Full Text] [Related]  

  • 24. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
    Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
    Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Helicobacter pylori eradication therapy in rosacea patients.
    Boixeda de Miquel D; Vázquez Romero M; Vázquez Sequeiros E; Foruny Olcina JR; Boixeda de Miquel P; López San Román A; Alemán Villanueva S; Martín de Argila de Prados C
    Rev Esp Enferm Dig; 2006 Jul; 98(7):501-9. PubMed ID: 17022699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosacea and the gastrointestinal system.
    Searle T; Ali FR; Carolides S; Al-Niaimi F
    Australas J Dermatol; 2020 Nov; 61(4):307-311. PubMed ID: 32761824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
    Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosacea and Helicobacter pylori: interference of systemic antibiotic in the study of possible association.
    Bonamigo RR; Leite CS; Wagner M; Bakos L
    J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):424-5. PubMed ID: 11305393
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary antibiotic resistance and effectiveness of Helicobacter pylori triple therapy in ulcero-inflammatory pathologies of the upper digestive tract.
    Aguemon B; Struelens M; Devière J; Denis O; Golstein P; Salmon I; Nagy N
    Acta Gastroenterol Belg; 2005; 68(3):287-93. PubMed ID: 16268413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori eradication--understandable caution but no excuse for inertia.
    de Boer WA
    Aliment Pharmacol Ther; 1995 Feb; 9(1):85-6. PubMed ID: 7766750
    [No Abstract]   [Full Text] [Related]  

  • 31. The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
    Horvat D; Vcev A; Soldo I; Timarac J; Dmitrović B; Misević T; Ivezić Z; Kraljik N
    Coll Antropol; 2005 Jun; 29(1):139-42. PubMed ID: 16117312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori.
    Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Tamura K; Shimoyama T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S45-7. PubMed ID: 8574735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Helicobacter pylori and the treatment of gastric ulcer. Reflections and uncertainties].
    Dobrilla G; Piazzi L; Amplatz S
    An Med Interna; 1993 Feb; 10(2):91-7. PubMed ID: 8452981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on Helicobacter pylori research. Eradication.
    Graham DY; Realdi G; Bazzoli F; Dore MP; Ferrini G; Glupczynski Y; Kusstatscher S; Mura I; Naim G; Pilotto A; Sanna G; Scaglione F; Savarino V
    Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):626-8. PubMed ID: 9222741
    [No Abstract]   [Full Text] [Related]  

  • 35. [The therapy of Helicobacter pylori infection].
    Labenz J; Börsch G
    Dtsch Med Wochenschr; 1994 May; 119(18):669-72. PubMed ID: 8187614
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease.
    Labenz J; Börsch G
    Gut; 1994 Jan; 35(1):19-22. PubMed ID: 8307443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gastrotsepin in the therapy and prevention of peptic ulcer exacerbations associated with Helicobacter pylori bacteriosis].
    Grigor'ev PIa; Iakovenko AV; Vasil'ev IV
    Klin Med (Mosk); 1995; 73(1):50-2. PubMed ID: 7791310
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical inquiry: Should you test for H pylori in patients with nonulcer dyspepsia?
    Lanier JB; Wilder L
    J Fam Pract; 2011 Dec; 60(12):767-8. PubMed ID: 22163363
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current developments in Helicobacter pylori therapy].
    Labenz J
    Leber Magen Darm; 1996 Jul; 26(4):223-6. PubMed ID: 8965606
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antibiotic resistance in Helicobacter pylori and molecular methods for the detection of resistance].
    Demiray E; Yilmaz O
    Mikrobiyol Bul; 2005 Jul; 39(3):399-408. PubMed ID: 16358500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.